TY - JOUR
T1 - Clinical features and outcome in North American adults with moyamoya phenomenon
AU - Hallemeier, Christopher L.
AU - Rich, Keith M.
AU - Grubb, Robert L.
AU - Chicoine, Michael R.
AU - Moran, Christopher J.
AU - Cross, De Witte T.
AU - Zipfel, Gregory J.
AU - Dacey, Ralph G.
AU - Derdeyn, Colin P.
PY - 2006/6
Y1 - 2006/6
N2 - BACKGROUND AND PURPOSE - To describe baseline clinical features and outcomes of adults with moyamoya phenomenon treated at a single North American institution. METHODS - We identified 34 adults with moyamoya phenomenon by review of angiographic records. Clinical presentation and baseline stroke risk factors were obtained by chart review. Follow-up was obtained prospectively. A 5-year Kaplan-Meier stroke risk was calculated. RESULTS - The median age was 42 (range 20 to 79) years. Twenty-five were women. The initial symptom was ischemia, hemorrhage, or asymptomatic in 24, 7, and 3 patients, respectively. Twenty-two had bilateral involvement and 12 had unilateral moyamoya vessels. Baseline stroke risk factors were similar between groups. The median follow-up in 31 living patients was 5.1 (range 0.2 to 19.6) years. Fourteen patients were treated with surgical revascularization (20 total hemispheres). In medically treated symptomatic hemispheres, the 5-year risk of recurrent ipsilateral stroke was 65% after the initial symptom and 27% after angiographic diagnosis. Patients with bilateral involvement presenting with ischemic symptoms were at the highest risk of subsequent stroke (n=17, 5-year risk of stroke with medical treatment after first symptom of 82%). In surgically treated hemispheres, the 5-year risk of perioperative or subsequent ipsilateral stroke or death was 17%. This was significantly different compared with medical treatment after first symptom (P=0.02) but not after angiographic diagnosis. CONCLUSION - Moyamoya phenomenon in North American adults is associated with a high risk of recurrent stroke, particularly those with bilateral involvement and ischemic symptoms. These data suggest a potential benefit with surgery if diagnosis could be made earlier.
AB - BACKGROUND AND PURPOSE - To describe baseline clinical features and outcomes of adults with moyamoya phenomenon treated at a single North American institution. METHODS - We identified 34 adults with moyamoya phenomenon by review of angiographic records. Clinical presentation and baseline stroke risk factors were obtained by chart review. Follow-up was obtained prospectively. A 5-year Kaplan-Meier stroke risk was calculated. RESULTS - The median age was 42 (range 20 to 79) years. Twenty-five were women. The initial symptom was ischemia, hemorrhage, or asymptomatic in 24, 7, and 3 patients, respectively. Twenty-two had bilateral involvement and 12 had unilateral moyamoya vessels. Baseline stroke risk factors were similar between groups. The median follow-up in 31 living patients was 5.1 (range 0.2 to 19.6) years. Fourteen patients were treated with surgical revascularization (20 total hemispheres). In medically treated symptomatic hemispheres, the 5-year risk of recurrent ipsilateral stroke was 65% after the initial symptom and 27% after angiographic diagnosis. Patients with bilateral involvement presenting with ischemic symptoms were at the highest risk of subsequent stroke (n=17, 5-year risk of stroke with medical treatment after first symptom of 82%). In surgically treated hemispheres, the 5-year risk of perioperative or subsequent ipsilateral stroke or death was 17%. This was significantly different compared with medical treatment after first symptom (P=0.02) but not after angiographic diagnosis. CONCLUSION - Moyamoya phenomenon in North American adults is associated with a high risk of recurrent stroke, particularly those with bilateral involvement and ischemic symptoms. These data suggest a potential benefit with surgery if diagnosis could be made earlier.
KW - Cerebral hemorrhage
KW - Cerebral infarction
KW - Cerebral revascularization
KW - Moyamoya disease
KW - Retrospective studies
UR - http://www.scopus.com/inward/record.url?scp=33745119472&partnerID=8YFLogxK
U2 - 10.1161/01.STR.0000221787.70503.ca
DO - 10.1161/01.STR.0000221787.70503.ca
M3 - Article
C2 - 16645133
AN - SCOPUS:33745119472
SN - 0039-2499
VL - 37
SP - 1490
EP - 1496
JO - Stroke
JF - Stroke
IS - 6
ER -